Showing results (21-30 of 108) with videos related to
Sort By:
Pageof 11
Anticancer Research|February 11, 2015
Angiogenic markers in plasma cell myeloma patients treated with novel agentsMichael Medinger, Jörg Halter, Dominik Heim, et al.Therapeutische Umschau. Revue Therapeutique|March 12, 2020
[Hematopoietic cell transplantation - essentials on indication, patient referral and long term follow up]Jörg P Halter, Sabine Gerull, Christian Arranto, et al.International Journal of Laboratory Hematology|November 27, 2019
Peripheral blood schistocytes in the acute phase after allogeneic or autologous stem cell transplantation assessed by digital microscopyMeropi Karakioulaki, Maria Martinez, Michael Medinger, et al.Cancer Genomics & Proteomics|July 2, 2016
Gene-expression Profiling in Patients with Plasma Cell Myeloma Treated with Novel AgentsMichael Medinger, Jörg Halter, Dominik Heim, et al.Bone Marrow Transplantation|April 1, 2022
Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantationClaire Seydoux, Raphael Battegay, Joerg Halter, et al.European Journal of Haematology|March 30, 2007
Oral health risks associated with HLA-types of patients undergoing hematopoietic stem cell transplantationTereza Dobr, Jakob Passweg, Catherine Weber, et al.Leukemia Research|April 24, 2017
Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaMichael Medinger, Deborah Zeiter, Dominik Heim, et al.Experimental Hematology|July 26, 2005
No evidence of plasticity in hair follicles of recipients after allogeneic hematopoietic stem cell transplantationAlicia Rovó, Sandrine Meyer-Monard, Dominik Heim, et al.BMC Infectious Diseases|November 12, 2014
Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasisDanielle Vuichard, Maja Weisser, Christina Orasch, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 18, 2012
Allogeneic stem cell transplantation for relapsed or refractory lymphoma after conditioning with BEAM/fludarabine/TBIAlix O'Meara, Jörg Halter, Dominik Heim, et al.Pageof 11